Screener
Vertex Pharmaceuticals VRTX Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Vertex Pharmaceuticals’s reported figures.
The source filing: Vertex Pharmaceuticals’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000875320-26-000173
FAQ
- What is Vertex Pharmaceuticals's free cash flow?
- Vertex Pharmaceuticals (VRTX) reported free cash flow of $1.29B in Q1 2026.
- How has Vertex Pharmaceuticals's free cash flow changed year-over-year?
- Vertex Pharmaceuticals's free cash flow increased by 66.4% year-over-year, from $778.2M to $1.29B.
- What is the long-term trend for Vertex Pharmaceuticals's free cash flow?
- Over 3 years (2022 to 2025), Vertex Pharmaceuticals's free cash flow has grown at a -6.6% compound annual growth rate (CAGR), from $3.93B to $3.19B.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Vertex Pharmaceuticals's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude